| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/NDT/GFX209 |
| P8608 | Fatcat ID | release_ubspevrp4zertj3hpfl75ukf34 |
| P698 | PubMed publication ID | 28992120 |
| P50 | author | Stefano Stuard | Q57076088 |
| Bernard Canaud | Q90986675 | ||
| P2093 | author name string | Rosa Ramos | |
| Alejandro Martín-Malo | |||
| Rafael Pérez-García | |||
| Pedro Aljama | |||
| Francesc Moreso | |||
| Javier Varas | |||
| José Ignacio Merello | |||
| Miguel Pinedo | |||
| ORD Group | |||
| P2860 | cites work | Safety concerns about intravenous iron therapy in patients with chronic kidney disease | Q26764881 |
| Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality | Q30839550 | ||
| Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial | Q31827493 | ||
| Intravenous iron exposure and mortality in patients on hemodialysis | Q34455198 | ||
| Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease | Q34497292 | ||
| Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients | Q34506972 | ||
| Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. | Q35474305 | ||
| Iron requirements in hemodialysis | Q35633349 | ||
| Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients | Q35804172 | ||
| Associations between hemodialysis access type and clinical outcomes: a systematic review | Q36638364 | ||
| Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin | Q36677375 | ||
| Clinical aspects of iron use in the anemia of kidney disease | Q36710623 | ||
| Assessing iron status: beyond serum ferritin and transferrin saturation | Q36910512 | ||
| The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? | Q36910516 | ||
| Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation | Q36947373 | ||
| Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients | Q36977382 | ||
| Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis | Q38078662 | ||
| Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation | Q40980736 | ||
| Serum Ferritin Predicts Mortality Regardless of Inflammatory and Nutritional Status in Patients Starting Dialysis: A Prospective Cohort Study. | Q41020981 | ||
| Iron monitoring and supplementation: how do we achieve the best results? | Q41753697 | ||
| Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients | Q42218133 | ||
| A comparison of 12 algorithms for matching on the propensity score | Q43092770 | ||
| Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas | Q43292780 | ||
| Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study | Q43433524 | ||
| The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin | Q43654523 | ||
| Time-dependent associations between iron and mortality in hemodialysis patients | Q43818759 | ||
| Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement | Q45012876 | ||
| Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients | Q46217820 | ||
| Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference | Q46240911 | ||
| Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation | Q46442596 | ||
| Administration of parenteral iron and mortality among hemodialysis patients | Q47578282 | ||
| Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale. | Q47915626 | ||
| Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS). | Q53102532 | ||
| Cumulative iron dose and resistance to erythropoietin. | Q53150909 | ||
| Type of vascular access and survival among very elderly hemodialysis patients. | Q54737666 | ||
| Serum ferritin is a marker of morbidity and mortality in hemodialysis patients | Q57772288 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hemodialysis patient | Q126109077 |
| P304 | page(s) | 160-170 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Relationships between iron dose, hospitalizations and mortality in incident haemodialysis patients: a propensity-score matched approach | |
| P478 | volume | 33 |
| Q60918869 | Achievement of renal anemia KDIGO targets by two different clinical strategies - a European hemodialysis multicenter analysis |
| Q52581674 | Measurement of iron status in chronic kidney disease. |
| Q97525886 | The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes-A Systematic Literature Review |
Search more.